Focused company thesis
One patient, buyer, provider, condition, program, price, distribution loop, and expansion path.
EVIDENCE AS OF 28 AUGUST 2026
Strong company design.
Zero market proof.
The thesis, authority model, consumer story, and synthetic product exist. Demand, clinical safety, provider adoption, outcomes, retention, and economics do not.
Built now.
These are product and design facts, not traction.
Fail-closed workflow
Ordered states, authoritative actors, sponsor privacy, USD service price, and PHP care estimate.
Truthful public product
An input-free sample with no booking, payment, medical care, or real data.
Not proven.
Every one of these gates remains closed.
Pain and willingness to pay
No observed activation, paid sponsor, retention, referral, or customer interview evidence.
Provider and workflow pull
No clinic, laboratory, pharmacy, HMO, public payer, or payment contract.
Safety and completion
No observed completion lift, recovery time, patient trust, incident rate, or clinical outcome.
What can kill it.
The company must change or stop if the pilot reveals any of these failures.
- 01
Providers will not enroll
The workflow cannot depend on founder-operated persuasion or duplicate clinical work.
- 02
Sponsors will not retain
The operational value must beat simply sending money.
- 03
Labor breaks the margin
Support must stay below the stated threshold instead of becoming concierge care.
- 04
Trust or authority fails
Privacy, authoritative completion, safety, or regulatory boundaries cannot be compromised.